Skip to main content
. 2010 Oct 4;28(34):5046–5053. doi: 10.1200/JCO.2010.29.6608

Table A1.

Guideline for Adverse Event Subsampling for Oncology Trials With ≥ 800 Patients to Achieve Similar Power to That of a 400-Patient Subsample of an 800-Patient Trial (specified power approach)

Total Study Size (1:1) Total Subsample Size (1:1)
800 400
1,200 500
1,500 590
2,000 680
3,000 780
6,000 890